Viridian Therapeutics Inc banner

Wall St Price Targets

VRDN Price Forecast
Based on 18 analysts

+39% Upside
from $30.87 today

Viridian Therapeutics Inc (VRDN)’s 12-month stock price forecast through November 2027 has a consensus target of $42.84, implying 39% upside. The forecast is based on price targets from 18 Wall Street analysts.

VRDN Analyst Rating
Based on 17 analysts

avg. 4.82 of 5
Strong buy
14 82%
Buy
3 18%
Hold
0 0%
Sell
0 0%
Strong sell
0 0%

Analysts rate VRDN Strong buy, with 17 of 17 recommending Buy or Strong buy.

Viridian Therapeutics Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is VRDN's stock price target?
Price Target
42.84 USD

According to Wall Street analysts, the average 1-year price target for VRDN is 42.84 USD with a low forecast of 33.33 USD and a high forecast of 56.7 USD.

What is the Revenue forecast for Viridian Therapeutics Inc?
Projected CAGR
49%

Over the last 13 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 8 years is 49%.

Back to Top